mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.03 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.03 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.03 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.04 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.04 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.04 |
mRNA |
StemRegenin 1 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.05 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.06 |